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Fine particles [particles ≤ 2.5 μm diam-
eter (PM2.5)] originate from both local and 
regional pollution sources. A large fraction of 
PM2.5 mass is associated with the combus-
tion of fuels such as gasoline, diesel, coal, oil, 
and wood. PM2.5 mass also includes crustal 
material (road dust and soil particles), sea salt, 
and biological particles. Factor analysis and 
source apportionment techniques [Brown 
et al. 2007; U.S. Environmental Protection 
Agency (EPA) 2008; Watson et al. 2002] have 
been used for many years to help policy regu-
lators identify sources of particle pollution. 
These techniques have been used to investigate 
associations between sources of particle pol-
lution and health effects including studies of 
adult mortality (Laden et al. 2000; Mar et al. 
2000; Ozkaynak and Thurston 1987; Taino 
et al. 2005), adult emergency department vis-
its (Sarnat et al. 2008), and adult and pediat-
ric hospital admissions (Andersen et al. 2007). 
Recently, one study associated specific sources 
of fine particles with respiratory morbidity in 
adults with asthma (Penttinen et al. 2006).
PM2.5 mass concentration has been asso-
ciated with adverse health effects in children, 
particularly children with asthma: increased 
respiratory morbidity and/or medication use 
(Gent et al. 2003; Johnston et al. 2006; Mar 
et al. 2004; Rabinovitch et al. 2006; Ranzi 
et al. 2004; Rodriguez et al. 2007; Slaughter 
et al. 2003); increased number of doctor visits 
for respiratory illness (Chardon et al. 2007; 
Hertz-Picciotto et al. 2007; Pino et al. 2004); 
and decreased lung function (Delfino et al. 
2004; Hong et al. 2007; Lewis et al. 2005; 
Moshammer et al. 2006; Trenga et al. 2006). 
Linking respiratory health effects to specific 
particle pollution sources is critical to efforts 
to develop cost-effective strategies to protect 
public health, particularly the respiratory 
health of vulnerable members of the popula-
tion such as children with asthma.
Annual PM2.5 levels at a monitoring site in 
New Haven, Connecticut, where subjects in the 
present study live, exceed the U.S. EPA annual 
standard of 15 μg/m3 (U.S. EPA 2009). We 
examined associations between daily exposure 
to PM2.5 components and sources identified 
through factor analysis and source apportion-
ment, and daily symptoms and medication use 
in children with asthma. Some of the results of 
this study have been previously reported in the 
form of an abstract (Gent et al. 2008).
Methods
Subjects. Subjects were drawn from a larger 
study population 4–12 years of age when 
enrolled between 2000 and 2003. Eligibility 
criteria were physician-diagnosed asthma and 
symptoms or medication use in the previous 
12 months. Subjects in the present analysis 
(n = 149) were restricted to those residing in 
New Haven County within 30 km of the air 
quality monitor. Study participants included 
siblings with asthma (one per family; n =88, 
59%) of infants enrolled in a birth cohort to 
study the development of asthma (Belanger 
et al. 2003), patients recruited from the Yale 
Pediatric Asthma Clinic (n =43, 29%), and 
children with asthma identified through a 
survey on childhood asthma conducted in the 
New Haven public schools (n = 18, 12%). 
In addition to abundant mobile sources of 
air pollution (e.g., interstate highways 95, 
91, 84), New Haven is home to stationary 
sources including small manufacturing enter-
prises, power plants, and a harbor handling 
ships that deliver heating oil for New England 
(U.S. EPA 2008). New Haven County, pop-
ulation 824,008, covers an area of 2,233 km2 
(863 mi2) (U.S. Census Bureau 2000). Yale 
University Human Investigation Committee 
approved the study, and all respondents 
(mothers of study subjects) gave informed 
consent prior to participation.
Data collection. During the enrollment 
visit, a research assistant administered a 
questionnaire to the child’s mother to col-
lect demographic, medical history, and home 
environment information. Mothers recorded 
daily symptoms [wheeze, persistent cough 
(defined as coughing throughout the day), 
shortness of breath, chest tightness, night 
symptoms] and medication use (rescue 
medication including bronchodilators, and 
maintenance medication including steroids, 
cromolyn sodium, and leukotriene inhibitors) 
on study diaries and reported this information 
during monthly telephone interviews. Dates 
away from New Haven during the follow-up 
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Ba c k g r o u n d: Exposure to ambient fine particles [particulate matter ≤ 2.5 µm diameter (PM2.5)] 
is a potential factor in the exacerbation of asthma. National air quality particle standards consider 
total mass, not composition or sources, and may not protect against health impacts related to spe-
cific components.
oB j e c t i v e: We examined associations between daily exposure to fine particle components and 
sources, and symptoms and medication use in children with asthma. 
Me t h o d s : Children with asthma (n = 149) 4–12 years of age were enrolled in a year-long study. 
We analyzed particle samples for trace elements (X-ray fluorescence) and elemental carbon (light 
reflectance). Using factor analysis/source apportionment, we identified particle sources (e.g., motor 
vehicle emissions) and quantified daily contributions. Symptoms and medication use were recorded 
on study diaries. Repeated measures logistic regression models examined associations between 
health outcomes and particle exposures as elemental concentrations and source contributions. 
re s u l t s: More than half of mean PM2.5 was attributed to traffic-related sources motor vehicles 
(42%) and road dust (12%). Increased likelihood of symptoms and inhaler use was largest for 3-day 
averaged exposures to traffic-related sources or their elemental constituents and ranged from a 10% 
increased likelihood of wheeze for each 5-µg/m3 increase in particles from motor vehicles to a 28% 
increased likelihood of shortness of breath for increases in road dust. Neither the other sources iden-
tified nor PM2.5 alone was associated with increased health outcome risks. 
co n c l u s i o n s : Linking respiratory health effects to specific particle pollution composition or 
sources is critical to efforts to protect public health. We associated increased risk of symptoms and 
inhaler use in children with asthma with exposure to traffic-related fine particles.
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period were reported at an exit interview and 
were not used in the analysis.
Exposure measurements. Filter analysis. 
PM2.5 filter samples (n = 1,181) were col-
lected between 1 August 2000 and 3 February 
2004 from the Stiles Street monitoring site 
(98% of the filters) or the State Street site 
(within 3 km). Filters were analyzed by X-ray 
fluorescence (XRF) (Desert Research Institute, 
Reno, Nevada) (Watson et al. 1999). A list 
of the 51 elements analyzed is presented in 
the Supplemental Material, Table 1 (avail-
able online at http://www.ehponline.org/
members/2009/0800335/suppl.pdf). 
Light reflectance analysis. Before XRF, 
elemental carbon (EC) concentrations were 
determined using an optical reflectance tech-
nique (Cyrys et al. 2003; Janssen et al. 2001; 
Kinney et al. 2000). See Supplemental Material 
for further details (available online at http://
www.ehponline.org/members/2009/0800335/
suppl.pdf). 
Source apportionment. We analyzed daily 
concentrations of 17 elements [see Supplemental 
Material, Table 1 (available online at http://
www.ehponline.org/members/2009/0800335/
suppl.pdf)] as well as EC using principal com-
ponent analysis with an orthogonal (varimax) 
rotation in SAS (version 9.1; SAS Institute Inc., 
Cary, NC) (Kavouras et al. 2001; Thurston 
and Spengler 1985). We calculated daily scores 
for each factor by multiplying the normalized 
elemental concentrations by the respective 
standardized elemental scoring coefficient and 
factor, then summing across all component 
products. Scores were rescaled to concentra-
tions in micrograms per cubic meter by regress-
ing total PM2.5 concentration on factor scores 
and obtaining the product of each factor score 
with its regression coefficient. Rescaled factor 
scores, or daily source contributions, were used 
as exposures in the health effects analyses. 
Six sources of PM2.5 were identified based 
on loadings (or correlations) of elements on 
each of the six factors determined by factor 
analysis. The factor with high loadings for 
EC and trace elements zinc, lead, and copper 
was attributed to motor vehicle emissions. 
The factor road dust was associated with ele-
ments of terrestrial origin such as silicon, iron, 
aluminum, and calcium as well as barium, 
which is a tracer for tire wear particles. The 
sulfur factor represents particles from regional 
sources and was highly correlated with the 
elements sulfur and phosphorus. The factor 
with a high potassium loading was attributed 
to biomass burning. The oil factor represents 
oil combustion emissions from power plants 
and home heating and was characterized by 
the presence of vanadium and nickel. Finally, 
the sea salt factor was associated with the ele-
ments sodium and chlorine.
Data analysis. The association between 
daily elemental concentrations or source 
contributions and daily respiratory symptoms 
and rescue medication use was examined with 
repeated measures logistic regression (SAS 
Institute Inc.). Models used generalized esti-
mating equations (GEE) specifying a 1-day lag 
autoregressive structure (AR1) for the health 
outcomes correlation matrices. All models 
were adjusted for season using sine and cosine 
functions of date to capture annual cycles [i.e., 
cos((date/365) × 2π) and sin((date/365) × 2π)], 
day of week (for weekly cycles), and date (to 
control for time trends over the 4-year course 
of the study). Because sources were uncorre-
lated by design (orthogonal rotation of factors), 
all six sources were included simultaneously in 
health effects models. Gaseous co-pollutants 
(nitrogen dioxide, carbon monoxide, sulfur 
dioxide, ozone) were examined separately 
in models that also included all six sources. 
Models included year-round data except for 
the co-pollutant model with O3, which is mon-
itored only in warm months. Health effects of 
elements included in the factor analysis, all six 
sources, and PM2.5 were examined for same-
day exposures [lag0 (L0)] as well as exposures 
lagged by 1 or 2 days (L1, L2) or the mean of 
lagged days 0–2 (L02). Tests for goodness of fit 
were performed using the Hosmer–Lemeshow 
statistic for logistic regression.
Results
Demographic characteristics of study partici-
pants are shown in Table 1. Most subjects were 
male (60%), ≥ 8 years of age (53%) (mean ± SD 
= 8 ± 2 years), and self-reported as white (56%). 
More than one-third of the adult respondents 
had a college degree (36%). Environmental 
tobacco smoke exposure was reported in 6% of 
the homes. Subjects participated for a mean of 
313 ± 92 days [median 366; interquartile range 
(IQR) 54 days]. The distribution of daily symp-
toms and medication use is shown in Table 2. 
The most frequently experienced symptom was 
persistent cough (reported by 86%), followed 
by wheeze (76%), which was experienced by 
subjects for a median of 19 days (IQR 29) or 
8 days (IQR 24), respectively, of the year of 
follow-up. Subjects experienced shortness of 
breath or chest tightness (reported by two-thirds 
of the subjects) less frequently for a median of 
4 (IQR 14) days each, and used short-acting 
inhalers (reported by 80%) for a median of 18 
(IQR 47) days. Nearly one-third of the subjects 
had moderate to severe persistent asthma dur-
ing the year-long follow-up study (Table 2). 
All subjects resided 0.9–27 km from the air 
Table 1. Personal characteristics for children par-
ticipating in a year-long prospective study (n = 149), 
New Haven, Connecticut, August 2000–January 
2004.
Enrollment characteristic  No. (%)
Sex 
  Male   89 (59.7)
  Female   60 (40.3)
Ethnicity 
  White   84 (56.4)
  Black   36 (24.2)
  Hispanic   27 (18.1)
  Other   2 (1.3)
Age at enrollment (years) 
  < 8   70 (47.0)
  ≥ 8   79 (53.0)
Mother’s education (years)a 
  < 12   13 (8.7)
  12–15   83 (55.7)
  > 15   53 (36.0)
Environmental exposure to tobacco smoke 
  No  140 (94.0)
  Yes   9 (6.0)
aThe adult respondent was the subject’s mother in all but 
two homes.
Table 2. Distribution of daily symptoms, daily 
inhaler use, and mean asthma severity during a 
year-long prospective study (n = 149), New Haven, 
Connecticut, August 2000–January 2004.
Variable  No. (%)
Symptoms and inhaler use during  
12-month study period (days) 
  Wheeze 
  None   35 (23.5)
  1–7   36 (24.2)
  8–14   22 (14.8)
  15–21   15 (10.1)
  22–29   11 (7.4)
  ≥ 30   30 (20.1)
  Persistent cough 
  None   20 (13.5)
  1–7   31 (21.0)
  8–14   12 (8.1)
  15–21   17 (11.5)
  22–29   21 (14.2)
  ≥ 30   47 (31.8)
  Shortness of breath 
  None   46 (30.9)
  1–7   43 (28.9)
  8–14   23 (15.4)
  15–21   9 (6.0)
  22–29   9 (6.0)
  ≥ 30   19 (12.8)
  Chest tightness 
  None   49 (32.9)
  1–7   44 (29.5)
  8–14   20 (13.4)
  15–21   9 (6.0)
  22–29   7 (4.7)
  ≥ 30   20 (13.4)
  Short-acting inhaler use 
  None   29 (19.5)
  1–7   28 (18.8)
  8–14   14 (9.4)
  15–21   11 (7.4)
  22–29   11 (7.4)
  ≥ 30   56 (37.6)
  Asthma severity (GINA score)a 
  0 No symptoms/medication   5 (3.4)
  1 Intermittent   66 (44.9)
  2 Mild persistent   29 (19.7)
  3 Moderate persistent   30 (20.4)
  4 Severe persistent   17 (11.6)
aA five-point asthma severity score [from 0 (no symptoms 
or medication use) to 4 (severe persistent)], based on the 
Global Initiative for Asthma guidelines (U.S. Department of 
Health and Human Services 2002) was calculated for each 
month of the study. The mean severity was the arithmetic 
mean of the 12 monthly severity scores.Gent et al.
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pollution monitor site (mean ± SD = 10.2 ± 
8.4 km). The mean number of subjects under 
observation each day was 36 ± 8 and ranged 
from 10 to 49. The mean number of subjects 
experiencing symptoms or using short-acting 
inhalers each day was as follows: shortness of 
breath or chest tightness 3 ± 3%; wheeze 5 ± 
4%; persistent cough 8 ± 5%; and inhaler use 
12 ± 6% (Figure 1A,B). 
Mean level of PM2.5 during the study was 
17.0 ± 9.8 μg/m3, which is above the U.S. 
annual standard for fine particles of 15 μg/m3 
(U.S. EPA 2009). The contributions from each 
source to PM2.5 mass and to elemental com-
ponents of PM2.5 are given in Table 3. The 
mean estimated and measured mass are given 
as well as the percent root mean square error 
(%RMSE), defined as 100 × (|estimated con-
centration – measured concentration|/mea-
sured concentration). Elemental components of 
PM2.5 are grouped according to the source with 
which they were most strongly associated. For 
example, the motor vehicle source contributed 
62% of the estimated mean EC mass (961.3 
of 1554.8 ng/m3) and 77% of the mean Zn 
mass (22.3 of 29.0 ng/m3). On average, over 
the 4 years of the study, over half of daily PM2.5 
came from the two traffic-related sources motor 
vehicles [median (IQR) 42.5% (26.7%)] and 
road dust [12.3% (13.8%)] (bottom of Table 2). 
An additional 28.7% (30.3%) of daily PM2.5 
came from regional sulfur sources. 
The associations between PM2.5 elemental 
components and daily symptoms or medica-
tion use are presented in Table 4. Individual 
elements in fine particle mass may come 
from more than one source but are listed in 
Table 4 according to the source with which 
they were most strongly associated (Table 3). 
Associations for same-day exposure (L0) and 
exposures averaged over the same day and 
previous 2 days (L02) are shown in Table 4. 
Exposures lagged by 1 or 2 days (L1, L2) 
are included in Table 2 in the Supplemental 
Material (available online at http://www.
ehponline.org/members/2009/0800335/
suppl.pdf). In general, trace elements originat-
ing from the motor vehicle, road dust, bio-
mass burning, and oil sources are associated 
with symptoms and/or medication use. For 
example, a significantly increased likelihood 
of wheeze, shortness of breath, chest tight-
ness, or short-acting inhaler use is associated 
with each 1,000-ng/m3 increase in EC. The 
strongest associations were found for the 3-day 
averaged exposures to the elemental constitu-
ents of road dust. No associations were found 
between individual elements associated with 
sulfur or sea salt sources and symptoms or 
medication use. Total PM2.5 was not signifi-
cantly associated with any symptoms or medi-
cation use [see Supplemental Material, Table 3 
(available online at http://www.ehponline.org/
members/2009/0800335/suppl.pdf)].
Daily source contributions to PM2.5 
are illustrated for the 4 years of the study in 
Figure 1C–1H. Results of logistic regression 
models examining associations between health 
outcomes and PM2.5 sources are shown in 
Table 5 for same-day exposures (Table 5, L0 
model) and exposures averaged over the same 
day and previous 2 days (Table 5, L02 model). 
Source exposures lagged by 1 or 2 days 
(L1, L2) are included in the Supplemental 
Material, Table 3 (available online at http://
www.ehponline.org/members/2009/0800335/
suppl.pdf). For same-day or 3-day averaged 
exposures, each 5-μg/m3 increase in PM2.5 
mass concentration coming from either motor 
vehicles or road dust is consistently associated 
with increases in the likelihood of respiratory 
symptoms or inhaler use (Table 5). Reduced 
likelihood of wheeze or inhaler use is associ-
ated with 5-μg/m3 increases in the same day, 
but not for lagged exposures to the sulfur 
source. Significant reductions in the likelihood 
of wheeze were also associated with exposures 
to the biomass burning source. 
The effect of adding a gaseous co-  pollutant 
(NO2, CO, SO2, or O3) to the source exposure 
Figure 1. Daily prevalence of wheeze (A) and short-acting inhaler use (B). Daily PM2.5 source concentra-
tions of motor vehicle (C), road dust (D), sulfur (E), biomass burning (F), oil (G), and sea salt (H). Dotted line 
at left of x-axis indicates warmer months (April–September). n = 149 children, New Haven, Connecticut, 
August 2000–January 2004. 
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model is shown for wheeze and short-acting 
inhaler use in Table 6. For example, the addi-
tion of any of the gaseous co-pollutants to the 
source exposure model reduces the effect of the 
motor vehicle source on wheeze. Interestingly, 
in the source model that also includes NO2 
(another marker for traffic), each 20-ppb 
increase in NO2 increases the likelihood of 
wheeze by 8% (p = 0.09). No significant asso-
ciations were seen in co-pollutant models 
between exposure and likelihood of persistent 
cough or chest tightness.
Discussion
Results of the source apportionment analysis 
suggest that over half of the mean PM2.5 can 
be attributed to traffic sources motor vehi-
cles and road dust, and that daily exposure to 
these sources is associated with increased risk 
of respiratory symptoms and inhaler use in 
children with asthma. Risks remain in mod-
els that include all six PM2.5 sources as well 
as one gaseous co-pollutant. Of co-pollut-
ants added to the model one at a time, NO2, 
which is a marker for traffic (Grieshop et al. 
2006), was also found to be an independent 
risk factor for increased wheeze (Table 6). 
In single-element analyses, EC, also con-
sidered a marker for traffic (Grieshop et al. 
2006; Sarnat et al. 2008), is itself associated 
with increased symptoms (wheeze, shortness 
of breath, chest tightness) and medication 
use (Table 4). Of the EC measured in PM2.5, 
88% was contributed by the traffic-related 
sources: 62% from motor vehicles and 26% 
from road dust (Table 3). Among elements 
associated with the road dust source, Ca 
appears to have the strongest association with 
symptoms (Table 4). Numerous studies have 
found that the composition of Ca in road 
dust is higher than that in the earth’s crust 
(Grieshop et al. 2006). Results from tunnel 
and chassis dynamometer studies have shown 
that Ca is emitted from light and heavy-duty 
vehicles and is possibly associated with the 
combustion of motor oil (Ning et al. 2008). 
The stronger associations with fine-particle 
Ca compared with other major terrestrial ele-
ments such as Al and Si suggests that it may 
be a better tracer of urban road dust.
A negative association was observed 
between biomass burning and wheeze 
(Table 5). Potassium, the tracer element for 
biomass burning source and an element used 
in firework propellant mixture, was present 
at high concentrations when Fourth of July 
displays took place (Moreno et al. 2007). 
When the analysis was rerun without the days 
with the five highest potassium values [all 
> 1,000 ng/m3 and all occurring in July (4 
July 2001, 2002, 2003; 5 July 2003; 7 July 
2002) (Figure 1F)], the negative association 
seen previously for wheeze remains but is no 
longer significant [odds ratio (OR) 0.85; p = 
0.29]. Of note is the high level of potassium 
measured on 7 July 2002, which is attribut-
able not to fireworks but to a smoke plume 
from a massive Canadian forest fire (Sigler 
et al. 2003). For our subjects, symptoms and 
medication use are at their lowest in summer 
and highest in winter (Figure 1A,B), and if 
these children with asthma were kept away 
from fireworks displays and/or kept indoors 
during the smoke plume days, this may have 
resulted in the apparent protective association 
with potassium levels.
Subjects who were in follow-up during 
the summer of 2001 also contributed data to 
an earlier analysis of O3 and respiratory health 
in southern New England (Gent et al. 2003). 
In that analysis, we found O3 exposure to be 
a risk for increased respiratory symptoms, but 
only among children taking asthma mainte-
nance medication (e.g., corticosteroids). The 
model with PM2.5 sources and O3 shown in 
Table 6 shows O3 to be a risk factor increasing 
the likelihood of wheeze by 8% (p = 0.08), 
but this model includes data from all children 
living in New Haven regardless of mainte-
nance medication status. Reanalysis stratified 
by maintenance medication use showed that 
every 50-ppb increase in O3 (8-hr average) 
resulted in a larger risk of wheeze for users of 
maintenance medication (n =76) [OR = 1.29; 
95% confidence interval (CI), 0.99–1.68; p = 
0.06] than for nonusers (n =63) (OR = 1.10; 
95% CI, 0.77–1.57; p = 0.60). Comparable 
results from the earlier report are given for a 
50-ppb increase in 1-hr O3: For children on 
maintenance medication (n = 130), the likeli-
hood of wheeze increases by 35% (OR = 1.35; 
95% CI, 1.11–1.65) (Gent et al. 2003). 
Although exposure to total PM2.5 mass has 
itself been shown to be a significant risk fac-
tor for adverse respiratory outcomes among 
children (Johnston et al. 2006; Mar et al. 
2004; Rabinovitch et al. 2006; Ranzi et al. 
2004; Rodriguez et al. 2007; Slaughter et al. 
2003), this is not always the case (Chimonas 
and Gessner 2007; Holguin et al. 2007). In 
a study of Medicaid claims for doctor visits 
for asthma in Anchorage, Alaska, the authors 
noted that the major constituent of their par-
ticles is geologic in origin (i.e., rock dust), 
and that annual levels of PM mass are low, 
6 μg/m3 (95% CI, 0.5–7.0). The authors found 
no association between exposure to PM2.5 mass 
Table 3. Source contributionsa to PM2.5 mass (µg/m3) and elemental (ng/m3) concentrations in New Haven, Connecticut, August 2000 – January 2004. 
  Source  Mass
Source  Motor vehicles  Road dust  Sulfur  Biomass burning  Oil  Sea salt   Estimated  Measured  %RMSE
Element (ng/m3)
  EC  961.3b  403.4  118.8  22.1  68.1  –19.0  1554.8  1894.5  17.9
  Zn  22.3b  2.6  0.8  0.5  1.7  1.0  29.0  23.0  26.3
  Pb  3.4b  0.5  0.6  0.5  —  0.1  5.1  4.9  4.0
  Cu  2.1b  1.3  0.5  1.8  0.2  —  6.0  6.3  5.5
  Se  0.4b  –0.1  0.2  —  0.0  0.0  0.5  0.5  3.5
  Si  –4.5  115.7b  5.7  4.8  2.0  2.2  125.9  117.0  7.6
  Fe  84.7  101.1b  3.0  11.6  12.2  –1.7  210.9  219.0  3.7
  Al  –7.0  54.8b  7.0  5.8  —  1.6  62.0  67.5  8.1
  Ca  17.8  29.1b  —  1.5  1.1  2.0  51.6  51.2  0.7
  Ba  2.9  4.9b  0.5  4.1  0.8  –0.4  12.7  12.6  0.4
  Ti  1.2  4.2b  0.5  0.9  —  —  6.9  7.4  6.3
  S  210.4  166.3  906.7b  75.4  18.7  26.0  1403.4  1451.8  3.3
  P  14.0  6.6  36.8b  2.6  1.5  —  61.5  64.8  5.2
  K  –8.0  13.8  12.4  60.5b  –2.7  3.7  79.6  63.2  25.8
  V  0.6  1.1  0.8  0.2  6.0b  0.2  8.9  9.9  9.4
  Ni  1.9  0.4  0.2  0.1  2.6b  0.2  5.6  5.2  6.9
  Na  20.9  29.3  37.0  4.4  —  47.0b  140.1  180.8  22.5
  Cl  20.5  —  –11.2  —  6.9  32.0b  48.7  29.6  64.4
PM2.5 (µg/m3)  6.6b  2.3  5.5  0.9  0.8  0.5  16.6  17.0  2.4
Daily source contribution to PM2.5 (%) 
  Median  42.5  12.3  28.7  4.4  2.2  1.2
  IQR  26.7  13.8  30.3  5.6  7.7  7.2 
—, nonsignificant contribution.
aMean concentration for 1,181 days between August 2000 and January 2004. bMaximum contribution from a particular source for each element. Gent et al.
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and health outcomes. On the other hand, sig-
nificant effects were seen between increases 
in PM10 mass concentrations (PM with aero-
dynamic diameter < 10 μm) and increased 
visits for asthma and prescriptions for inhal-
ers (Chimonas and Gessner 2007). In a study 
of asthmatic children and respiratory health 
in a busy, traffic-filled Mexican border town, 
Holguin et al. (2007) found no significant 
association between level of PM2.5 mass and 
respiratory health. However, using traffic as the 
exposure metric (calculated as traffic density 
in 50-m residential buffers) revealed a signifi-
cant risk for increased respiratory symptoms 
with increasing traffic (OR = 1.58; 95% CI, 
1.05–2.38) (Holguin et al. 2007).
Studies using proximity to traffic as 
an exposure metric suggest that children 
living near busy roads have impaired respi-
ratory health. Large studies of schoolchil-
dren in Munich (Nicolai et al. 2003) and 
Nottingham, United Kingdom (Venn et al. 
2001), have found that proximity of residence 
(< 50–90 m) to heavily traveled roads is asso-
ciated with increased risk of asthma symp-
toms. Studies of schoolchildren conducted 
in the Netherlands found increased health 
risks associated with proximity specifically to 
truck traffic and wheeze (Janssen et al. 2003), 
chronic respiratory symptoms (Van Vliet 
et al. 1997), and lung function (Brunekreef 
et al. 1997). Similar increased risk associa-
tions were found between black smoke (a 
proxy for diesel exhaust), measured at sub-
jects’ schools, and respiratory outcomes. No 
significant associations were found between 
respiratory symptoms and volume of auto-
mobile traffic. The strongest associations were 
found for children living within 300 m of a 
highway (Brunekreef et al. 1997). A smaller 
study in Cincinnati, Ohio (Ryan et al. 2005), 
found an increased risk of wheezing in infants 
associated with stop-and-go bus and truck 
traffic within 100 m of the residence. All of 
these studies suggest that proximity to traffic, 
in particular high-volume truck traffic, has a 
negative impact on the respiratory health of 
children. Rather than a metric based on prox-
imity to roads or traffic density, we used factor 
analysis and source apportionment techniques 
to examine exposures to potentially toxic por-
tions of particle mass and the health of chil-
dren residing in an area of significant mobile 
source activity. 
Table 4. ORs from separate repeated measures logistic regression analysesa of associations between daily respiratory symptoms and each daily elemental con-
centration of PM2.5. 
    Unit increase   Wheeze  Persistent cough  Shortness of breath  Chest tightness  Inhaler short-acting
Source/element  Lag  (ng/m3)  OR  p-Value  OR  p-Value  OR  p-Value  OR  p-Value  OR  p-Value
Motor vehicles
  EC  L0  1,000  1.04  0.04  1.01  0.42  1.06  0.001  1.03  0.20  1.01  0.15
  L02  1,000  1.07  0.06  1.03  0.23  1.12  0.01  1.10  0.04  1.02  0.40
  Zn  L0  10  1.00  0.69  1.00  0.60  1.02  0.001  1.00  0.72  1.00  0.41
  L02  10  1.00  0.98  1.00  0.94  1.04  0.06  1.03  0.13  1.01  0.53
  Pb  L0  5  1.02  0.31  1.02  0.25  1.03  0.11  1.02  0.31  1.01  0.06
  L02  5  1.07  0.13  1.05  0.12  1.12  0.01  1.10  0.02  1.04  0.10
  Cu  L0  5  1.01  0.59  1.02  0.13  1.06  0.01  1.03  0.23  1.01  0.22
  L02  5  1.02  0.67  1.05  0.04  1.06  0.21  1.04  0.39  1.01  0.46
  Se  L0  1  1.00  0.97  1.00  0.84  1.02  0.40  1.00  0.79  0.99  0.20
  L02  1  1.02  0.71  0.98  0.43  1.02  0.67  0.98  0.61  0.99  0.75
Road dust
  Si  L0  100  1.03  0.03  1.02  0.01  1.04  0.01  1.02  0.20  1.02  0.004
  L02  100  1.07  0.04  1.05  0.02  1.08  0.02  1.06  0.10  1.03  0.09
  Fe  L0  100  1.04  0.02  1.02  0.06  1.06  0.002  1.01  0.47  1.02  0.004
  L02  100  1.07  0.05  1.04  0.04  1.08  0.04  1.05  0.21  1.03  0.08
  Al  L0  50  1.02  0.17  1.03  0.002  1.05  0.002  1.02  0.21  1.02  0.02
  L02  50  1.07  0.03  1.06  0.01  1.09  0.004  1.07  0.04  1.02  0.11
  Ca  L0  50  1.07  0.02  1.05  0.01  1.10  0.002  1.04  0.26  1.04  0.01
  L02  50  1.14  0.04  1.09  0.03  1.18  0.01  1.14  0.07  1.04  0.17
  Ba  L0  10  0.99  0.57  1.00  0.83  1.04  0.02  1.01  0.63  1.01  0.08
  L02  10  0.99  0.81  1.00  0.81  1.03  0.38  1.02  0.51  1.01  0.36
  Ti  L0  5  1.00  0.59  1.00  0.57  1.01  0.01  1.00  0.34  1.00  0.72
  L02  5  1.01  0.56  1.01  0.29  1.03  0.05  1.01  0.52  1.00  0.66
Sulfur
  S  L0  1,000  0.98  0.43  1.00  0.84  1.01  0.63  0.99  0.80  0.99  0.13
  L02  1,000  1.00  0.99  1.02  0.27  1.01  0.79  1.02  0.68  1.00  0.81
  P  L0  50  0.98  0.39  1.00  0.75  1.01  0.61  1.00  0.88  0.98  0.15
  L02  50  0.99  0.89  1.03  0.30  1.01  0.78  1.02  0.67  1.00  0.99
Biomass burning
  K  L0  50  0.98  0.06  1.00  0.64  1.01  0.01  1.01  0.02  1.00  0.68
  L02  50  0.96  0.04  1.00  0.86  1.00  0.79  0.99  0.67  0.99  0.28
Oil
  V  L0  10  0.99  0.73  1.01  0.56  1.01  0.46  0.99  0.71  0.98  0.12
  L02  10  0.93  0.04  0.96  0.05  0.98  0.58  0.94  0.12  0.96  0.03
  Ni  L0  5  1.01  0.59  1.01  0.21  1.04  0.05  1.01  0.58  1.01  0.48
  L02  5  0.99  0.72  1.00  0.99  1.04  0.32  1.01  0.84  1.01  0.48
Sea salt
  Na  L0  100  0.98  0.23  1.00  0.58  1.00  0.94  0.99  0.43  0.99  0.35
  L02  100  0.97  0.29  0.98  0.21  0.99  0.74  0.98  0.61  0.99  0.37
  Cl  L0  10  1.00  0.89  1.00  0.31  1.00  0.89  1.00  0.24  1.00  0.69
   L02  10  1.00  0.81  1.00  0.06  1.00  0.80  1.00  0.65  1.00  0.83
Associations are shown for same-day exposure (L0) and averaged over the same day and previous 2 days (L02). n = 149 children with asthma, New Haven, Connecticut, August 
2000–January 2004.
aSeparate analyses were performed for each element and each respiratory symptom and medication use. Models were adjusted for season, day of week, and date. ORs are given for the 
unit increase given in the second column for each element (and EC). Individual elements in fine particle mass may come from more than one source but are listed here according to their 
major source. See Table 3 for the contribution of each source to each element’s total mass. Results from analyses using elemental exposures lagged by 1 or 2 days (L1, L2) are included 
in Supplemental Material, Table 2 (available online at http://www.ehponline.org/members/2009/0800335/suppl.pdf).Pediatric asthma and particle pollution
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One strength of this study is its longi-
tudinal design. More than 46,000 subject-days 
of data were available for analyses (resulting 
in small CIs) where each subject served as his 
or her own control for potential confounders. 
Effect estimates from analyses where sex, age, 
ethnicity, parental education level, and expo-
sure to environmental tobacco smoke were 
also included varied little from those shown in 
Table 6. For example, each 5-μg/m3 increase in 
exposure to motor vehicle source was associated 
with identical increased risks of wheeze and 
shortness of breath and inhaler use. Likewise, 
the risk estimates associated with exposure to 
road dust source were identical for persistent 
cough and inhaler use and slightly decreased 
for wheeze (OR = 1.09; 95% CI, 1.01–1.19) 
and shortness of breath (OR = 1.11; 95% CI, 
1.02–1.21) (for comparison, see Table 5). 
Goodness-of-fit tests suggest that the models 
for wheeze and chest tightness are reasonably 
good fits to the data (Table 5). There were no 
systematic patterns to the lack of fit for models 
for persistent cough, shortness of breath, or 
short-acting inhaler use. However, because of 
the repeated measurements, observations were 
not independent in any of the models, which 
may affect the interpretation of the Hosmer–
Lemeshow statistic. It is possible that the more 
frequently reported events of persistent cough 
and short-acting inhaler use (Table 2) may be 
associated with ambient air pollution in com-
bination with other factors (e.g., activity level) 
not included in the current study.
One limitation of our study is the lack 
of co-located EC calibration measurements. 
Previous studies have used thermal optical 
reflectance (TOR) to measure EC collected on 
quartz filters in co-located monitors. TOR, a 
relatively costly but accurate measure of EC, 
is used to calibrate EC estimated by the much 
less expensive light reflectance measures on 
Teflon filters. We assumed a factor of 1 based 
on calibration factors reported in other studies 
examining air pollution in urban settings (Cyrys 
et al. 2003; Kinney et al. 2000) and on our own 
results of TOR EC measurements on 30, co- 
located quartz filters [see Supplemental Material 
(available online at http://www.  ehponline.org/
members/2009/0800335/suppl.pdf)]. 
Another limitation to our study is our reli-
ance on a central site monitor. It is likely that 
measurements from this site, located on an 
on-ramp to I-95 at the southern edge of New 
Haven County, represent the highest end of 
the exposure distribution. Exposure error for 
regional sources, for example, sulfur, is prob-
ably low because of its homogeneity within 
the study area. On the other hand, local traffic 
exposures vary across the study area, which may 
have led to an overestimate of subjects’ expo-
sures to motor vehicle and road dust sources 
and an underestimate of health effects; that is, 
it is possible that levels lower than those used 
have significant adverse effects on respiratory 
health of children with asthma in our region. 
Determination of spatial variability of PM2.5 
away from central site monitors will be needed 
to improve assessment of exposures actually 
experienced by vulnerable populations.
Conclusions
The composition of ambient fine particles 
is complex, because it depends on emission 
sources and atmospheric processes. The U.S. 
EPA national air quality standard for PM2.5 
considers only mass and not composition 
(U.S. EPA 2009). However, health impacts 
associated with exposures to specific particle 
components or sources, especially for vulner-
able populations, may be missed with this 
aggregate characterization (Franklin et al. 
2008; Sarnat et al. 2008). Apportioning 
fine particle mass according to contributing 
sources may help unmask source-specific asso-
ciations. For children with asthma living in an 
area of noncompliance with PM2.5 standards, 
increased risk of daily symptoms and medi-
cation use was associated with daily traffic-
related fine particle sources.
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Table 5. ORs (95% CIs) from repeated measures logistic regression models of respiratory symptoms and 
rescue medication use and daily source concentrations of PM2.5. 
      Shortness    Inhaler
Source  Wheeze  Persistent cough  of breath   Chest tightness  short-acting
L0 model         
  Motor vehicles  1.05 (0.99–1.10)  1.02 (0.99–1.04)  1.06 (1.01–1.11)  1.02 (0.97–1.08)  1.02 (1.00–1.05)
  Road dust  1.10 (1.01–1.19)  1.06 (1.01–1.11)  1.12 (1.02–1.22)  1.04 (0.95–1.15)  1.06 (1.02–1.11)
  Sulfur  0.97 (0.94–1.00)  1.00 (0.98–1.01)  0.98 (0.94–1.02)  0.99 (0.94–1.03)  0.98 (0.97–1.00)
  Biomass burning  0.80 (0.66–0.98)  0.97 (0.92–1.03)  1.05 (0.95–1.17)  1.06 (0.95–1.18)  1.00 (0.96–1.03)
  Oil  1.02 (0.86–1.20)  1.02 (0.95–1.10)  1.07 (0.92–1.26)  0.99 (0.82–1.18)  0.98 (0.91–1.05)
  Sea salt  0.96 (0.86–1.07)  0.99 (0.92–1.07)  1.01 (0.92–1.12)  0.95 (0.84–1.08)  0.99 (0.94–1.04)
L02 model         
  Motor vehicles  1.10 (1.01–1.19)  1.03 (0.98–1.09)  1.12 (1.01–1.24)  1.08 (0.98–1.20)  1.03 (0.98–1.08)
  Road dust  1.26 (1.05–1.51)  1.16 (1.02–1.32)  1.28 (1.05–1.55)  1.20 (0.97–1.49)  1.09 (1.00–1.19)
  Sulfur  0.98 (0.92–1.04)  1.01 (0.98–1.05)  0.97 (0.90–1.04)  1.00 (0.92–1.08)  1.00 (0.97–1.03)
  Biomass burning  0.64 (0.46–0.88)  0.93 (0.81–1.06)  0.78 (0.52–1.18)  0.87 (0.62–1.22)  0.95 (0.87–1.04)
  Oil  0.80 (0.56–1.08)  0.84 (0.71–1.00)  0.94 (0.69–1.29)  0.80 (0.58–1.10)  0.92 (0.81–1.05)
  Sea salt  0.91 (0.82–1.16)  0.88 (0.77–1.01)  1.01 (0.79–1.29)  0.95 (0.71–1.27)  0.97 (0.88–1.07)
n = 149 children with asthma, New Haven, Connecticut, August 2000–January 2004. Separate logistic regression analyses 
were performed for each health outcome. Each model included the six PM2.5 sources listed, either as same-day concen-
trations (L0), or the concentration averaged over the same day and previous 2 days (L02), as well as variables control-
ling for season, day of week, and date. Logistic regressions were performed using GEE. All ORs are given for a 5-µg/m3 
increase in source concentration. 
Table 6. Effect of adding a gaseous co-pollutant to the source exposure model [OR (95% CI)].
  Co-pollutants
Outcome/source  Sources alone  NO2  CO  SO2  O3
Wheeze
  Motor vehicles  1.05 (0.99–1.10)  1.03 (0.98–1.08)  1.05 (0.99–1.11)  1.04 (0.99–1.09)  1.06 (0.97–1.16)
  Road dust  1.10 (1.01–1.19)  1.11 (1.02–1.20)  1.10 (1.01–1.19)  1.10 (1.01–1.19)  1.11 (1.01–1.23)
  Sulfur  0.97 (0.94–1.00)  0.96 (0.92–0.99)  0.97 (0.94–1.01)  0.97 (0.93–1.00)  0.95 (0.91–1.00)
  Biomass burning  0.80 (0.66–0.98)  0.79 (0.65–0.98)  0.80 (0.66–0.98)  0.79 (0.64–0.98)  0.74 (0.57–0.97)
  Oil  1.02 (0.86–1.20)  1.02 (0.87–1.21)  1.02 (0.86–1.20)  1.01 (0.86–1.19)  0.92 (0.62–1.39)
  Sea salt  0.96 (0.86–1.07)  0.96 (0.85–1.07)  0.96 (0.86–1.08)  0.95 (0.85–1.07)  1.01 (0.72–1.40)
  Co-pollutant    1.08 (0.99–1.18)  1.00 (0.94–1.07)  1.02 (0.96–1.09)  1.08 (0.99–1.18)
Short-acting inhaler use
  Motor vehicles  1.02 (1.00–1.05)  1.02 (0.99–1.04)  1.02 (0.99–1.05)  1.02 (0.99–1.04)  1.02 (0.98–1.07)
  Road dust  1.06 (1.02–1.11)  1.06 (1.02–1.10)  1.06 (1.02–1.11)  1.06 (1.02–1.11)  1.06 (1.00–1.13)
  Sulfur  0.98 (0.97–1.00)  0.98 (0.96–1.00)  0.98 (0.96–1.00)  0.98 (0.96–1.00)  0.97 (0.95–1.00)
  Biomass burning  1.00 (0.96–1.03)  1.00 (0.96–1.03)  0.99 (0.96–1.03)  0.99 (0.96–1.03)  0.99 (0.95–1.03)
  Oil  0.98 (0.91–1.05)  0.98 (0.91–1.05)  0.97 (0.91–1.04)  0.97 (0.91–1.04)  1.03 (0.88–1.22)
  Sea salt  0.99 (0.94–1.04)  0.99 (0.94–1.04)  0.99 (0.94–1.04)  0.99 (0.94–1.04)  1.01 (0.88–1.15)
  Co-pollutant     1.01 (0.97–1.06)  1.02 (0.98–1.05)  1.01 (0.99–1.04)  1.01 (0.97–1.05)
n = 149 children with asthma, New Haven, Connecticut, August 2000–January 2004. Separate repeated measures logistic 
regression analyses using GEE were performed for each health outcome. Each model includes the six particle sources 
(same-day exposure) as well as season, day of week, and date. Gaseous co-pollutants were added to the source expo-
sure model one at a time. ORs for sources are given for a 5-µg/m3 increase in source concentration; ORs for co-pollutants 
are given for each 20 ppb (NO2, ozone), 0.5 ppm (CO), or 5 ppb (SO2). Pearson correlations between PM2.5 sources and 
criteria pollutants were < 0.20 except for motor vehicles with NO2 (r = 0.49), CO (r = 0.59), SO2 (r = 0.45); road dust with NO2 
(r = 0.37), O3 (r = 0.58); and oil with CO (r = 0.22), SO2 (r = 0.32).Gent et al.
1174  v o l u m e  117 | n u m b e r 7 | July 2009  •  Environmental Health Perspectives
Brown SG, Frankel A, Raffuse SM, Roberts PT, Hafner HR, 
Anderson DJ. 2007. Source apportionment of fine particu-
late matter in Phoenix, AZ, using positive matrix factoriza-
tion. J Air Waste Manag Assoc 57:741–752.
Brunekreef B, Janssen NAH, de Hartog JJ, Harssema H, 
Knape M, Van Vliet P. 1997. Air pollution from truck traf-
fic and lung function in children living near motorways. 
Epidemiology 8:298–303.
Chardon B, Lefranc A, Granados D, Gremy I. 2007. Air pollu-
tion and doctors’ house calls for respiratory diseases in 
the Greater Paris area (2000–2003). Occup Environ Med 
64:320–324.
Chimonas M-AR, Gessner BD. 2007. Airborne particulate matter 
from primarily geologic, non-industrial sources at levels 
below National Ambient Air Quality Standards is associ-
ated with outpatient visits for asthma and quick-relief 
medication prescriptions among children less than 20 
years old enrolled in Medicaid in Anchorage, Alaska. 
Environ Research 103:397–404.
Cyrys J, Heinrich J, Hoek G, Meliefste K, Lewne M, Gehring U, 
et al. 2003. Comparison between different traffic-related 
particle indicators: elemental carbon (EC), PM2.5 mass, 
and absorbance. J Exp Anal Environ Epidemiol 13:134–143.
Delfino RJ, Quintana PJE, Floro J, Gastanaga VM, Samimi BS, 
Kleinman MT, et al. 2004. Association of FEV1 in asthmatic 
children with personal and microenvironmental exposure 
to airborne particulate matter. Environ Health Perspect 
112:932–941.
Franklin M, Koutrakis P, Schwartz J. 2008. The role of particle 
composition on the association between PM2.5 and mor-
tality. Epidemiology 19:680–689.
Gent JF, Koutrakis P, Leaderer BP. 2008. Childhood asthma: asso-
ciation of exposure to fine particle sources with respiratory 
symptoms [Abstract]. Am J Respir Crit Care Med 177:A186.
Gent JF, Triche EW, Holford TR, Belanger K, Bracken MB, 
Beckett WS, et al. 2003. Association of low-level ozone 
and fine particles with respiratory symptoms in children 
with asthma. JAMA 290:1859–1867.
Grieshop AP, Lipsky EM, Pekney NJ, Takahama S, Robinson AL. 
2006. Fine particle emission factors from vehicles in a 
highway tunnel: effects of fleet composition and season. 
Atmos Environ 40:S287–S298.
Hertz-Picciotto I, Baker RJ, Yap P-S, Dostal M, Joad JP, Lipsett M, 
et al. 2007. Early childhood lower respiratory illness and air 
pollution. Environ Health Perspect 115:1510–1518.
Holguin F, Flores S, Ross Z, Corez M, Molina M, Molina L, et al. 
2007. Traffic-related exposures, airway function, inflam-
mation, and respiratory symptoms in children. Am J Resp 
Crit Care Med 176(12):1236–1242.
Hong Y-C, Hwang S-S, Kim JH, Lee K-H, Lee H-J, Lee K-H, 
et al. 2007. Metals in particulate pollutants affect peak 
expiratory flow of schoolchildren. Environ Health Perspect 
115:430–434.
Janssen NAH, Brunekreef B, Van Vliet P, Aarts F, Meliefste K, 
Harssema H, et al. 2003. The relationship between air pollu-
tion from heavy traffic and allergic sensitization, bronchial 
hyperresponsiveness, and respiratory symptoms in Dutch 
schoolchildren. Environ Health Perspect 111:1512–1518.
Janssen  NAH,  van  Vliet  PHN,  Aarts  F,  Harssema  H, 
Brunekreef B. 2001. Assessment of exposure to traffic 
related air pollution of children attending schools near 
motorways. Atmos Environ 35:3875–3884.
Johnston FH, Webby RJ, Pilotto LS, Bailie RS, Parry DL, 
Halpin SJ. 2006. Vegetation fires, particulate air pollution 
and asthma: a panel study in the Australian monsoon trop-
ics. Int J Environ Health Res 16(6):391–404.
Kavouras IG, Koutrakis P, Cereceda-Balic F, Oyola P. 2001. 
Source apportionment of PM10 and PM2.5 in five Chilean 
cities using factor analysis. J Air Waste Manag Assoc 
51:451–464.
Kinney PL, Aggarwal M, Northridge ME, Hanssen NAH, 
Shepard P. 2000. Airborne concentrations of PM2.5 and 
diesel exhaust particles on Harlem sidewalks: a communi-
ty-based pilot study. Environ Health Perspect 108:213–218.
Laden F, Neas LM, Dockery DW, Schwartz J. 2000. Association 
of fine particulate matter from different sources with 
daily mortality in six U.S. cities. Environ Health Perspect 
108:941–947.
Lewis TC, Robins TG, Dvonch JT, Keeler GJ, Yip FY, Mentz GB, 
et al. 2005. Air pollution-associated changes in lung func-
tion among asthmatic children in Detroit. Environ Health 
Perspect 113:1068–1075.
Mar TF, Larson TV, Stier RA, Claiborn C, Koenig JQ. 2004. An 
analysis of the association between respiratory symptoms 
in subjects with asthma and daily air pollution in Spokane, 
Washington. Inhal Toxicol 16:809–815.
Mar TF, Norris GA, Koenig JQ, Larson TV. 2000. Associations 
between air pollution and mortality in Phoenix, 1995–1997. 
Environ Health Perspect 108:347–353.
Moreno T, Querol X, Alastuey A, Minguillon M, Pey J, 
Rodriguez S, et al. 2007. Recreational atmospheric pol-
lution episodes: Inhalable metalliferous particles from 
firework displays. Atmos Environ 41:913–922.
Moshammer H, Hutter H-P, Hauck H, Neuberger M. 2006. Low 
levels of air pollution induce changes of lung function in a 
panel of schoolchildren. Eur Respir J 27(6):1138–1143.
Nicolai T, Carr D, Weiland SK, Duhme H, von Ehrenstein O, 
Wagner C, et al. 2003. Urban traffic and pollutant expo-
sure related to respiratory outcomes and atopy in a large 
sample of children. Eur Respir J 21:956–963.
Ning Z, Polidori A, Schauer JJ, Sioutas C. 2008. Emission fac-
tors of PM species based on freeway measurements and 
comparison with tunnel and dynamoter studies. Atmos 
Environ 42:3099–3114.
Ozkaynak H, Thurston GD. 1987. Associations between 1980 
U.S. mortality rates and alternative measures of airborne 
particle concentration. Risk Anal 7(4):449–461.
Penttinen P, Vallius M, Tiittanen P, Ruuskanen J, Pekkanen J. 
2006. Source-specific fine particles in urban air and respi-
ratory function among adult asthmatics. Inhal Toxicol 
18:191–198.
Pino P, Walter T, Oyarzun M, Villegas R, Romieu I. 2004. Fine 
particulate matter and wheezing illnesses in the first year 
of life. Epidemiology 15(6):702–708.
Rabinovitch N, Strand M, Gelfand EW. 2006. Particulate lev-
els are associated with early asthma worsening in chil-
dren with persistent disease. Am J Resp Crit Care Med 
173(10):1098–1105.
Ranzi A, Gambini M, Spattini A, Galassi C, Sesti D, Bedeschi M, 
et al. 2004. Air pollution and respiratory status in asthmatic 
children: hints for a locally based preventive strategy. 
AIRE study. Eur J Epidemiol 19(6):567–576.
Rodriguez C, Tonkin R, Heyworth J, Kusel M, DeKlerk N, Sly P, 
et al. 2007. The relationship between outdoor air quality 
and respiratory symptoms in young children. Int J Environ 
Health Res 17(5):351–360.
Ryan PH, LeMasters G, Biagini J, Bernstein D, Grinshpun SA, 
Shukla R, et al. 2005. Is it traffic type, volume, or distance? 
Wheezing in infants living near truck and bus traffic. 
J Allerg Clin Immunol 116:279–284.
Sarnat JA, Marmur A, Klein M, Kim E, Russell AG, Sarnat SE, 
et al. 2008. Fine particle sources and cardiorespiratory 
morbidity: an application of chemical mass balance and 
factor analytical source-apportionment methods. Environ 
Health Perspect 116:459–466.
Sigler JM, Lee X, Munger W. 2003. Emission and long-range 
transport of gaseous mercury from a large-scale Canadian 
boreal forest fire. Environ Sci Tech 37(19):4343–4347.
Slaughter JC, Lumley T, Sheppard L, Koenig JQ, Shapiro GG. 
2003. Effects of ambient air pollution on symptom severity 
and medication use in children with asthma. Ann Allergy 
Asthma Immunol 91(4):346–353.
Taino M, Tuomisto JT, Hanninen O, Aarnio P, Koistinen KJ, 
Jantunen MJ, et al. 2005. Health effects caused by primary 
fine particulate matter (PM2.5) emitted from buses in the 
Helsinki metropolitan area, Finland. Risk Anal 25(1):151–160.
Thurston GD, Spengler JD. 1985. A quantitative assessment of 
source contributions to inhalable particulate matter pollu-
tion in metropolitan Boston. Atmos Environ 19(1):9–25.
Trenga CA, Sullivan JH, Schildcrout JS, Shepherd KP, 
Shapiro GG, Liu LJS, et al. 2006. Effect of particulate air 
pollution on lung function in adult and pediatric subjects in 
a Seattle panel study. Chest 129(6):1614–1622.
U.S. Census Bureau. 2000. United States Census 2000. 
Available: http://www.census.gov/main/www/cen2000.
html [accessed 1 April 2008].
U.S. Department of Health and Human Services. 2002. 
Global Initiative for Asthma, Global Strategy for Asthma 
Management and Prevention 02-3659. Washington, 
DC:National Institutes of Health, National Heart, Lung, and 
Blood Institute.
U.S. EPA (U.S. Environmental Protection Agency). 2008. 
National Emissions Inventory (NEI). Available: http://www.
epa.gov/ttn/chief/software/speciate/index.html [accessed 
1 June 2009]. 
U.S. EPA (U.S. Environmental Protection Agency). 2009. 
National Ambient Air Quality Standards (NAAQS) for 
Particulate Matter (PM). Available: http://www.epa.gov/
ttn/naaqs/standards/pm/s_pm_index.html [accessed 1 
January 2009].
Van Vliet P, Knape M, de Hartog J, Janssen N, Harssema H, 
Brunekreef B. 1997. Motor vehicle exhaust and chronic 
respiratory symptoms in children living near freeways. 
Environ Res 74:122–132.
Venn AJ, Lewis SA, Cooper M, Hubbard R, Britton J. 2001. 
Living near a main road and the risk of wheezing illness in 
children. Am J Respir Crit Care Med 164:2177–2180.
Watson JG, Chow JC, Frazier CA. 1999. X-ray fluorescence 
analysis of ambient air samples. In: Elemental Analysis 
of Airborne Particles (Landsberger S, Creatchman M, 
eds). Amsterdam: Gordon and Breach Science Publishers, 
67–96.
 Watson JG, Zhu T, Chow JC, Engelbrecht J, Fujita EM, 
Wilson WE. 2002. Receptor modeling application frame-
work for particle source apportionment. Chemosphere 
49:1093–1136.